Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress
Restricted accessResearch articleFirst published online December, 2014
Ethanol extract of propolis protects endothelial cells from oxidized low density lipoprotein-induced injury by inhibiting lectin-like oxidized low density lipoprotein receptor-1-mediated oxidative stress
Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), as the primary oxidized low-density lipoprotein (ox-LDL) receptor on endothelial cells, plays a crucial role in endothelial injury, which is a driving force in the initiation and development of atherosclerosis. Our previous studies have shown that ethanol extract of propolis (EEP) promotes reverse cholesterol transport and inhibits atherosclerotic lesion development. However, the protective effects of EEP against ox-LDL-induced injury in endothelial cells and the underlying mechanisms are still unknown. This study was designed to test the hypothesis that EEP attenuates ox-LDL-induced endothelial oxidative injury via modulation of LOX-1-mediated oxidative stress. Our results showed that exposure of human umbilical vein endothelial cells (HUVECs) to ox-LDL (100 mg/L) led to the decrease in cell viability and increase in lactate dehydrogenase (LDH) release, caspase-3 activation, and apoptosis, whereas pretreatment with EEP (7.5, 15 and 30 mg/L) protected against such damages in a dose-dependent manner. In addition, EEP mitigated ox-LDL uptake by HUVECs and attenuated ox-LDL-upregulated LOX-1 expression both at the mRNA and protein levels. Moreover, EEP suppressed the ox-LDL-induced oxidative stress as assessed by decreased nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation, reactive oxygen species (ROS), and malondialdehyde (MDA) generation as well as increased antioxidant enzyme activities. Similar results were observed in the anti-LOX-1 antibody or diphenyleneiodonium (DPI)-pretreated HUVECs. These data indicate that EEP may protect HUVECs from ox-LDL-induced injury and that the mechanism at least partially involves its ability to inhibit endothelial LOX-1 upregulation and subsequent oxidative stress.
KzhyshkowskaJNeyenCGordonS. Role of macrophage scavenger receptors in atherosclerosis. Immunobiology2012; 217: 492–502.
5.
XuSOguraSChenJLittlePJMossJLiuP. LOX-1 in atherosclerosis: biological functions and pharmacological modifiers. Cell Mol Life Sci2013; 70: 2859–72.
6.
YoshimotoRFujitaYKakinoAIwamotoSTakayaTSawamuraT. The discovery of LOX-1, its ligands and clinical significance. Cardiovasc Drugs Ther2011; 25: 379–91.
7.
MehtaJLSanadaNHuCPChenJDandapatASugawaraFSatohHInoueKKawaseYJishageKSuzukiHTakeyaMSchnackenbergLBegerRHermonatPLThomasMSawamuraT. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res2007; 100: 1634–42.
8.
HuCDandapatASunLChenJMarwaliMRRomeoFSawamuraTMehtaJL. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res2008; 79: 287–93.
9.
JiangJXZhangSJLiuYNLinXXSunYHShenHJYanXFXieQM. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells. Eur J Pharmacol2014; 727C: 43–51.
10.
CominaciniLRigoniAPasiniAFGarbinUDavoliACampagnolaMPastorinoAMLo CascioVSawamuraT. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem2001; 276: 13750–5.
11.
Ulrich-MerzenichGZeitlerH. The lectin-like oxidized low-density lipoprotein receptor-1 as therapeutic target for atherosclerosis, inflammatory conditions and longevity. Expert Opin Ther Targets2013; 17: 905–19.
12.
FarooquiTFarooquiAA. Beneficial effects of propolis on human health and neurological diseases. Front Biosci (Elite Ed)2012; 4: 779–93.
13.
Medić-SarićMRastijaVBojićMMalesZ. From functional food to medicinal product: systematic approach in analysis of polyphenolics from propolis and wine. Nutr J2009; 8: 33–50.
14.
Viuda-MartosMRuiz-NavajasYFernández-LópezJPérez-AlvarezJA. Functional properties of honey, propolis, and royal jelly. J Food Sci2008; 73: R117–24.
15.
WangKPingSHuangSHuLXuanHZhangCHuF. Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from Chinese propolis (poplar type). Evid Based Complement Alternat Med2013; 2013: 127672–82.
16.
BlonskaMBronikowskaJPietszGCzubaZPSchellerSKrolW. Effects of ethanol extract of propolis (EEP) and its flavones on inducible gene expression in J774A.1 macrophages. J Ethnopharmacol2004; 91: 25–30.
17.
FangYSangHYuanNSunHYaoSWangJQinS. Ethanolic extract of propolis inhibits atherosclerosis in ApoE-knockout mice. Lipids Health Dis2013; 12: 123–8.
18.
YuYSiYSongGLuoTWangJQinS. Ethanolic extract of propolis promotes reverse cholesterol transport and the expression of ATP-binding cassette transporter A1 and G1 in mice. Lipids2011; 46: 805–11.
19.
YaoSSangHSongGYangNLiuQZhangYJiaoPZongCQinS. Quercetin protects macrophages from oxidized low-density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress-C/EBP homologous protein pathway. Exp Biol Med (Maywood)2012; 237: 822–31.
20.
YaoSZongCZhangYSangHYangMJiaoPFangYYangNSongGQinS. Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression. J Atheroscler Thromb2013; 20: 94–107.
HigashiYNomaKYoshizumiMKiharaY. Endothelial function and oxidative stress in cardiovascular diseases. Circ J2009; 73: 411–8.
24.
LeeMJLeeHSJungHJLeeCSKimJEMoonHIParkWH. Caesalpinia sappan L. ameliorates hypercholesterolemia in C57BL/6 mice and suppresses inflammatory responses in human umbilical vein endothelial cells (HUVECs) by antioxidant mechanism. Immunopharmacol Immunotoxicol2010; 32: 671–9.
25.
VisavadiyaNPSoniBDalwadiN. Evaluation of antioxidant and anti-atherogenic properties of Glycyrrhiza glabra root using in vitro models. Int J Food Sci Nutr2009; 60(Suppl 2): 135–49.
26.
SampathkumarMTKasettiRBNabiSASudarshanPRSwapnaSApparaoC. Antihyperlipidemic and antiatherogenic activities of Terminalia pallida Linn. fruits in high fat diet-induced hyperlipidemic rats. J Pharm Bioallied Sci2011; 3: 449–52.
27.
Abd El-HadyFKHegaziAGWollenweberE. Effect of Egyptian propolis on the susceptibility of LDL to oxidative modification and its antiviral activity with special emphasis on chemical composition. Z Naturforsch C2007; 62: 645–55.
28.
ChenMNarumiyaSMasakiTSawamuraT. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J2001; 355: 289–96.
29.
Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C, Sledzinska A, Mocharla P, Breitenstein A, Lohmann C, Stein S, von Lukowicz T, Kurrer MO, Borén J, Becher B, Tanner FC, Landmesser U, Matter CM, Lüscher TF. Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. Eur Heart J. Epub ahead of print 2014. DOI: 10.1093/eurheartj/eht532.
30.
InoueKAraiYKuriharaHKitaTSawamuraT. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res2005; 97: 176–84.
31.
PirilloACatapanoAL. Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers2013; 35: 413–8.
32.
ChenJMehtaJLHaiderNZhangXNarulaJLiD. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res2004; 94: 370–6.
33.
GuLBaiWLiSZhangYHanYGuYMengGXieLWangJXiaoYShanLZhouSWeiLFerroAJiY. Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One2013; 8: e65477–87.
34.
WangYKHongYJYaoYHHuangXMLiuXBZhangCYZhangLXuXL. 6-Shogaol protects against oxidized LDL-induced endothelial injruries by inhibiting oxidized LDL-evoked LOX-1 signaling. Evid Based Complement Alternat Med2013; 2013: 503521–33.
35.
HofnagelOLuechtenborgBEschertHWeissen-PlenzGSeversNJRobenekH. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins. Arterioscler Thromb Vasc Biol2006; 26: 604–10.
36.
TsaiKLChenLHChiouSHChiouGYChenYCChouHYChenLKChenHYChiuTHTsaiCSOuHCKaoCL. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway. Mol Nutr Food Res2011; 55(Suppl 2): S227–40.
37.
HanJShuvaevVVMuzykantovVR. Targeted interception of signaling reactive oxygen species in the vascular endothelium. Ther Deliv2012; 3: 263–76.
38.
ChenXPXunKLWuQZhangTTShiJSDuGH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein-induced apoptosis in human umbilical vein endothelial cells: role of reactive oxygen species. Vascul Pharmacol2007; 47: 1–9.
39.
LassègueBSan MartínAGriendlingKK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res2012; 110: 1364–90.
40.
RomeroMJiménezRSánchezMLópez-SepúlvedaRZarzueloMJO'ValleFZarzueloAPérez-VizcaínoFDuarteJ. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis2009; 202: 58–67.
